They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

I agree with the House Budget Committee that our government's $36-trillion debt is a problem. But who should sacrifice to ...

By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Researchers used data from the National Health and Nutrition Examination Survey to examine the prevalence of obesity in the United States.

The other half received information on "childproofing" their home. "In the United States, childhood obesity rates remain alarmingly high, with over 22% of children 6 to 19 years old classified as ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Per a research conducted by Goldman Sachs, the obesity market in the United States is expected to reach $100 billion by 2030. This is also evident from the fact that all large drugmakers are ...

March is Colon Cancer Awareness Month. Colon cancer is the second leading cause of cancer deaths in the United States. "We ...

A National Institutes of Health study aims to find out whether ultraprocessed foods lead people to eat more. And, if so, why?